CN103721047B - 治疗放射性肺炎的药物 - Google Patents
治疗放射性肺炎的药物 Download PDFInfo
- Publication number
- CN103721047B CN103721047B CN201310508360.8A CN201310508360A CN103721047B CN 103721047 B CN103721047 B CN 103721047B CN 201310508360 A CN201310508360 A CN 201310508360A CN 103721047 B CN103721047 B CN 103721047B
- Authority
- CN
- China
- Prior art keywords
- weight portion
- radix
- weight
- weight portions
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 104
- 206010037765 Radiation pneumonitis Diseases 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 61
- 229940079593 drugs Drugs 0.000 claims abstract description 31
- 241000857908 Chimonanthus nitens Species 0.000 claims abstract description 21
- 241000190633 Cordyceps Species 0.000 claims abstract description 21
- 241000628997 Flos Species 0.000 claims abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- 239000007788 liquid Substances 0.000 claims description 28
- 210000000214 Mouth Anatomy 0.000 claims description 27
- 239000000843 powder Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000000284 extract Substances 0.000 claims description 16
- 238000010298 pulverizing process Methods 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 14
- 240000005428 Pistacia lentiscus Species 0.000 claims description 12
- 230000002829 reduced Effects 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- WXMKPNITSTVMEF-UHFFFAOYSA-M Sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 6
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 claims description 6
- 238000004090 dissolution Methods 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 235000010234 sodium benzoate Nutrition 0.000 claims description 6
- 239000004299 sodium benzoate Substances 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 230000003068 static Effects 0.000 claims description 6
- 230000001954 sterilising Effects 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 238000007792 addition Methods 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- 235000005035 ginseng Nutrition 0.000 claims description 3
- 206010023232 Joint swelling Diseases 0.000 claims 1
- 240000004371 Panax ginseng Species 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 235000014347 soups Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 36
- 201000010099 disease Diseases 0.000 abstract description 17
- 206010035664 Pneumonia Diseases 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 5
- 206010028980 Neoplasm Diseases 0.000 abstract description 3
- 235000008216 herbs Nutrition 0.000 abstract description 3
- 238000001794 hormone therapy Methods 0.000 abstract description 3
- 231100000486 side effect Toxicity 0.000 abstract description 3
- 210000004072 Lung Anatomy 0.000 description 53
- 206010011224 Cough Diseases 0.000 description 38
- 210000004369 Blood Anatomy 0.000 description 37
- 239000008280 blood Substances 0.000 description 37
- 210000003734 Kidney Anatomy 0.000 description 20
- 241000700159 Rattus Species 0.000 description 19
- 229940088597 Hormone Drugs 0.000 description 17
- 239000005556 hormone Substances 0.000 description 17
- 238000005507 spraying Methods 0.000 description 15
- 210000004185 Liver Anatomy 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 13
- 231100000614 Poison Toxicity 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- 230000001047 pyretic Effects 0.000 description 10
- 238000001959 radiotherapy Methods 0.000 description 10
- 230000001988 toxicity Effects 0.000 description 10
- 231100000419 toxicity Toxicity 0.000 description 10
- 239000003390 Chinese drug Substances 0.000 description 9
- 208000001848 Dysentery Diseases 0.000 description 9
- 210000001519 tissues Anatomy 0.000 description 9
- 239000003440 toxic substance Substances 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 8
- 230000003419 expectorant Effects 0.000 description 8
- 239000003172 expectorant agent Substances 0.000 description 8
- 230000001717 pathogenic Effects 0.000 description 8
- 208000006673 Asthma Diseases 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 7
- 210000002216 Heart Anatomy 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 230000029058 respiratory gaseous exchange Effects 0.000 description 7
- 230000002522 swelling Effects 0.000 description 7
- 210000000952 Spleen Anatomy 0.000 description 6
- 210000002784 Stomach Anatomy 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 230000001737 promoting Effects 0.000 description 6
- 230000035812 respiration Effects 0.000 description 6
- 210000001124 Body Fluids Anatomy 0.000 description 5
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 5
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N Prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 5
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N Tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 5
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 5
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000002496 gastric Effects 0.000 description 5
- 230000002757 inflammatory Effects 0.000 description 5
- 201000003453 lung abscess Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 231100000915 pathological change Toxicity 0.000 description 5
- 230000036285 pathological change Effects 0.000 description 5
- 229960004618 prednisone Drugs 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 208000002173 Dizziness Diseases 0.000 description 4
- 210000001624 Hip Anatomy 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 4
- 206010022114 Injury Diseases 0.000 description 4
- 208000008425 Protein Deficiency Diseases 0.000 description 4
- 210000004915 Pus Anatomy 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- -1 gold silver Chemical compound 0.000 description 4
- 201000001881 impotence Diseases 0.000 description 4
- 210000000056 organs Anatomy 0.000 description 4
- 230000002685 pulmonary Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 206010003549 Asthenia Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000010228 Erectile Dysfunction Diseases 0.000 description 3
- 206010016286 Febrile disease Diseases 0.000 description 3
- 210000003026 Hypopharynx Anatomy 0.000 description 3
- 206010027327 Menstrual disease Diseases 0.000 description 3
- 229960002275 Pentobarbital Sodium Drugs 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 210000002966 Serum Anatomy 0.000 description 3
- 230000003213 activating Effects 0.000 description 3
- 230000003110 anti-inflammatory Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 210000004027 cells Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000003203 everyday Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000006199 nebulizer Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- QGMRQYFBGABWDR-OGFXRTJISA-M sodium;5-ethyl-5-[(2R)-pentan-2-yl]pyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC[C@@H](C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-OGFXRTJISA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010000496 Acne Diseases 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 210000004204 Blood Vessels Anatomy 0.000 description 2
- 210000000481 Breast Anatomy 0.000 description 2
- 240000000218 Cannabis sativa Species 0.000 description 2
- 210000001736 Capillaries Anatomy 0.000 description 2
- 206010008479 Chest pain Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 210000002889 Endothelial Cells Anatomy 0.000 description 2
- 208000006572 Human Influenza Diseases 0.000 description 2
- 206010020718 Hyperplasia Diseases 0.000 description 2
- 206010022000 Influenza Diseases 0.000 description 2
- 206010022437 Insomnia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 210000003127 Knee Anatomy 0.000 description 2
- 208000009856 Lung Disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 210000003800 Pharynx Anatomy 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 2
- 206010067953 Radiation fibrosis Diseases 0.000 description 2
- 206010072736 Rheumatic disease Diseases 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 210000003491 Skin Anatomy 0.000 description 2
- 208000010110 Spontaneous Platelet Aggregation Diseases 0.000 description 2
- 210000003802 Sputum Anatomy 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 230000001154 acute Effects 0.000 description 2
- 230000003064 anti-oxidating Effects 0.000 description 2
- 230000001166 anti-perspirant Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- 230000003115 biocidal Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 201000008286 diarrhea Diseases 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 230000002708 enhancing Effects 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000002440 hepatic Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000001678 irradiating Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000006011 modification reaction Methods 0.000 description 2
- 230000000242 pagocytic Effects 0.000 description 2
- 230000001575 pathological Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000000268 renotropic Effects 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002269 spontaneous Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 201000010874 syndrome Diseases 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- 230000003442 weekly Effects 0.000 description 2
- 210000001015 Abdomen Anatomy 0.000 description 1
- 210000000683 Abdominal Cavity Anatomy 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 210000004404 Adrenal Cortex Anatomy 0.000 description 1
- 210000004100 Adrenal Glands Anatomy 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 240000004657 Alloteropsis cimicina Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 210000000709 Aorta Anatomy 0.000 description 1
- 208000002399 Aphthous Stomatitis Diseases 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- 210000004556 Brain Anatomy 0.000 description 1
- 208000000409 Breast Neoplasms Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 230000036536 Cave Effects 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 235000017898 Digitaria ciliaris Nutrition 0.000 description 1
- 206010013023 Diphtheria Diseases 0.000 description 1
- 241000668709 Dipterocarpus costatus Species 0.000 description 1
- 206010013781 Dry mouth Diseases 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 210000000416 Exudates and Transudates Anatomy 0.000 description 1
- 210000003608 Feces Anatomy 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 210000003194 Forelimb Anatomy 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 210000000232 Gallbladder Anatomy 0.000 description 1
- 208000001786 Gonorrhea Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 210000003714 Granulocytes Anatomy 0.000 description 1
- 206010018830 Haematemesis Diseases 0.000 description 1
- 206010018987 Haemorrhage Diseases 0.000 description 1
- 210000003128 Head Anatomy 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000007514 Herpes Zoster Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000000509 Infertility Diseases 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- 210000000265 Leukocytes Anatomy 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- 210000002751 Lymph Anatomy 0.000 description 1
- 210000002540 Macrophages Anatomy 0.000 description 1
- 206010025482 Malaise Diseases 0.000 description 1
- 208000004396 Mastitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 210000004080 Milk Anatomy 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029410 Night sweats Diseases 0.000 description 1
- 210000001672 Ovary Anatomy 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000287882 Pavo Species 0.000 description 1
- 241000504571 Pedicularis muscicola Species 0.000 description 1
- 210000003516 Pericardium Anatomy 0.000 description 1
- 206010036596 Premature ejaculation Diseases 0.000 description 1
- 210000002307 Prostate Anatomy 0.000 description 1
- 208000005069 Pulmonary Fibrosis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229940076185 Staphylococcus aureus Drugs 0.000 description 1
- 210000001562 Sternum Anatomy 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- 208000008203 Tachypnea Diseases 0.000 description 1
- 206010043089 Tachypnoea Diseases 0.000 description 1
- 210000001550 Testis Anatomy 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 210000001541 Thymus Gland Anatomy 0.000 description 1
- 210000001685 Thyroid Gland Anatomy 0.000 description 1
- 206010043949 Tongue discolouration Diseases 0.000 description 1
- 206010044008 Tonsillitis Diseases 0.000 description 1
- 208000004371 Toothache Diseases 0.000 description 1
- 206010069363 Traumatic lung injury Diseases 0.000 description 1
- 206010068760 Ulcers Diseases 0.000 description 1
- 210000004291 Uterus Anatomy 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 230000003187 abdominal Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 201000004073 acute interstitial pneumonia Diseases 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 231100000494 adverse effect Toxicity 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003444 anaesthetic Effects 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 230000002429 anti-coagulation Effects 0.000 description 1
- 230000001754 anti-pyretic Effects 0.000 description 1
- 230000000259 anti-tumor Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000000740 bleeding Effects 0.000 description 1
- 231100000319 bleeding Toxicity 0.000 description 1
- 230000000903 blocking Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000001413 cellular Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 201000000258 compensatory emphysema Diseases 0.000 description 1
- 230000003750 conditioning Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 201000005977 erythrokeratodermia variabilis Diseases 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001605 fetal Effects 0.000 description 1
- 230000003328 fibroblastic Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000003814 hair luster Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002949 hemolytic Effects 0.000 description 1
- 230000002607 hemopoietic Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001146 hypoxic Effects 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 230000001861 immunosuppresant Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001771 impaired Effects 0.000 description 1
- 230000001976 improved Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000003902 lesions Effects 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 231100000516 lung damage Toxicity 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 230000003448 neutrophilic Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000000414 obstructive Effects 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 244000052769 pathogens Species 0.000 description 1
- 230000002093 peripheral Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000002085 persistent Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002035 prolonged Effects 0.000 description 1
- 230000000171 quenching Effects 0.000 description 1
- 230000002285 radioactive Effects 0.000 description 1
- 101500018159 rat Transforming growth factor beta-1 Proteins 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000000552 rheumatic Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000002000 scavenging Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004936 stimulating Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 201000005665 thrombophilia Diseases 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000224 toxic side effect Toxicity 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 230000002087 whitening Effects 0.000 description 1
Abstract
Description
分组 | 时间 |
2周 | 4周 | 8周 | |
空白组 | 207.05±53.76 | 277.99±63.45 | 307.10±56.20 |
模型组 | 458.29±47.02 | 528.38±61.74 | 722.33±45.43 |
中药组 | 386.72±85.33 | 413.18±57.56 | 533.05±65.12 |
激素组 | 408.15±77.84 | 481.08±95.05 | 659.29±118.76 |
中药+激素组 | 259.43±53.26 | 343.72±66.89 | 404.85±117.30 |
组别 | 例数 | 显效 | 有效 | 无效 | 总有效 |
对照组 | 80 | 38(47.5) | 31(38.8) | 11(13.8) | 73(86.3) |
治疗组 | 71 | 33(46.5) | 28(39.4) | 10(14.1) | 61(85.9) |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310508360.8A CN103721047B (zh) | 2013-10-24 | 治疗放射性肺炎的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310508360.8A CN103721047B (zh) | 2013-10-24 | 治疗放射性肺炎的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103721047A CN103721047A (zh) | 2014-04-16 |
CN103721047B true CN103721047B (zh) | 2016-11-30 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104013868B (zh) | 一种治疗慢性阻塞性肺疾病的中药组合物及其制备方法 | |
CN107158223A (zh) | 用于清热解毒与消炎的中药制剂及其制备方法 | |
CN103432412B (zh) | 一种治疗乳腺增生的药物及其制备方法 | |
CN103417911B (zh) | 化疗辅助用中药组合物 | |
CN104771578A (zh) | 用于治疗变应性鼻炎的中药 | |
CN103721047B (zh) | 治疗放射性肺炎的药物 | |
CN106310047A (zh) | 一种治疗湿热血燥和脉络不和引起的皮肤病的中药组合物 | |
CN102861292B (zh) | 一种治疗食管癌的药物及其制备方法 | |
CN105106634A (zh) | 一种治疗急性阑尾炎的中药制剂及其应用 | |
CN102614466B (zh) | 一种治疗肺腺癌的中药制剂 | |
CN105521332A (zh) | 治疗肛裂的中药组合物及其制备方法和应用 | |
CN104758466A (zh) | 治疗急性胆囊炎的中药制剂及制法 | |
CN105343523A (zh) | 一种治疗肺部肿瘤放疗并发症的药物 | |
CN103432335B (zh) | 一种治疗乳糜尿的药物及其制备方法 | |
CN106215097A (zh) | 一种治疗慢性肺心病的中药制剂及其制备方法 | |
CN103721047A (zh) | 治疗放射性肺炎的药物 | |
CN106421257A (zh) | 一种治疗感冒的中西药颗粒及其制备方法 | |
CN106110086A (zh) | 一种可有效治疗慢性阻塞性肺疾病的中药组合物 | |
CN105169329A (zh) | 小儿腹痛宁脐贴及其制备方法 | |
CN104784608B (zh) | 改善肿瘤化疗后毒副反应的药物的制备方法 | |
CN104800724B (zh) | 改善肿瘤化疗后毒副反应的药物 | |
CN104547672A (zh) | 用于预防痔疮发作和治疗痔疮的中药组合物 | |
CN104435922A (zh) | 一种治疗动脉硬化的中药组合物 | |
CN103405597B (zh) | 一种治疗动脉硬化的药物及其制备方法 | |
CN106266709A (zh) | 一种治疗睡眠障碍的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160623 Address after: Qingdao City, Shandong province 266033 Taiwan Liu Road No. 138 B Applicant after: Yang Gaolin Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 Minmetals building room 801-A Applicant before: Qingdao Huaren Technology Incubator Co., Ltd. |
|
CB03 | Change of inventor or designer information |
Inventor after: Ren Jin Inventor after: Yu Dan Inventor after: Yang Junling Inventor after: Yin Jinzhi Inventor after: Yan Bingdi Inventor after: Gao Rong Inventor after: Qu Danhua Inventor before: Sun Xia |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20161020 Address after: 130012 Changchun Qianjin Street, Jilin, No. 2699 Applicant after: Jilin University Address before: Qingdao City, Shandong province 266033 Taiwan Liu Road No. 138 B Applicant before: Yang Gaolin |
|
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20161130 Termination date: 20181024 |